Longbio Pharma (suzhou) Co., Ltd.

Researchers are testing an experimental injectable drug called LP-003 in people with wheat allergy that triggers allergic reactions during exercise. The Phase II trial enrolls 12 participants aged 12 to 60 who have a history of wheat or gluten allergy and react to a small amount …

This trial is testing an investigational drug called LP-003, a type of antibody that may block allergic responses. The goal is to see if it can increase the amount of peanut protein that people with peanut allergy can eat without having allergic symptoms. The study involves about…

This study tests an experimental drug called LP-005, given as an injection into the gums, for people with moderate-to-severe gum disease (periodontitis). About 100 adults aged 18-70 will receive either the drug or a placebo to see if it reduces gum inflammation, bleeding, and bon…